| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $1.34 (Miss by $-0.11) |
| EPS GAAP Actual | $1.34 (Miss by $-0.11) |
| Revenue Actual | $4.163B |
| Revenue Surprise | Beat by $4163M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.89216 |
| EPS GAAP Estimate | $1.89216 |
| Revenue Estimate | $5.200430953B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 8.08644 | 14.8 | 7.96969 | 8.24029 | 3 |
| Dec 2027 | 7.69162 | 15.56 | 7.58057 | 7.83796 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.53 | -0.26059 | 4.163B | -20.8% | -1046.45M |
| FQ1 2025 (Mar 2025) | 1.71 | 1.71 | 4.84B | -6.38% | 4840M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 4.928B | -0.85% | 4928M |
| FQ3 2024 (Sep 2024) | 2.7 | 2.7 | 4.952B | -3.63% | 4952M |
| FQ2 2024 (Jun 2024) | 1.61 | 1.61 | 5.029B | -2.09% | 5029M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 5.149B | -0.89% | 5149M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 4.97B | 0.12% | 4970M |
| FQ3 2023 (Sep 2023) | 1.74 | 1.74 | 5.132B | 1.54% | 5132M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.89216
Consensus Revenue Estimates
5.200430953B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.8642 | -- | 1.80741 | 1.91291 | 4 |
| FQ3 2027 (Sep 2027) | 2.1029 | -- | 2.03884 | 2.15785 | 3 |
| FQ2 2027 (Jun 2027) | 2.1592 | -- | 2.09343 | 2.21562 | 4 |
| FQ1 2027 (Mar 2027) | 2.0122 | -- | 1.9509 | 2.06478 | 3 |
| FQ4 2026 (Oct 2026) | 1.98475 | -- | 1.93977 | 2.02072 | 3 |
| FQ3 2026 (Jul 2026) | 1.91614 | -- | 1.87271 | 1.95086 | 3 |
| FQ2 2026 (Jun 2026) | 1.87082 | 18.22 | 1.83223 | 1.90844 | 3 |
| FQ1 2026 (Mar 2026) | 1.89397 | 9.71 | 1.8549 | 1.93206 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.98B | -- | 4.86B | 5.08B | 3 |
| FQ3 2027 (Sep 2027) | 4.98B | -- | 4.86B | 5.08B | 3 |
| FQ2 2027 (Jun 2027) | 5.02B | -- | 4.9B | 5.12B | 3 |
| FQ1 2027 (Mar 2027) | 5.09B | -- | 4.97B | 5.19B | 3 |
| FQ4 2026 (Oct 2026) | 5.4B | -- | 5.3B | 5.47B | 4 |
| FQ3 2026 (Jul 2026) | 5.39B | -- | 5.29B | 5.46B | 5 |
| FQ2 2026 (Jun 2026) | 5.34B | 22.09 | 5.26B | 5.43B | 5 |
| FQ1 2026 (Mar 2026) | 5.33B | 9.13 | 5.24B | 5.41B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
1
EPS # of in-lines
3
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.79059 | 1.53 | -0.26059 | -17.03% |
| FQ1 2025 (Mar 2025) | 1.71 | 1.71 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 2.7 | 2.7 | 100% | |
| FQ2 2024 (Jun 2024) | 1.61 | 1.61 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
| FQ3 2023 (Sep 2023) | 1.74 | 1.74 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $5.21B | $4.16B | $-1046.45M | -25.14% |
| FQ1 2025 (Mar 2025) | $0B | $4.84B | $4840M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $4.93B | $4928M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.95B | $4952M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.03B | $5029M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.15B | $5149M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $4.97B | $4970M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $5.13B | $5132M | 100% |